“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“The RNA team has helped us with tax and financial reporting-oriented valuation work. Its nice to work with a firm that not only understands the intricacies of reporting requirements but actually understands the drug development business.”
“We have been working with RNA for several years. They are responsive, reliable, understand the nuances of our business and help us with modeling expertise that exceeds the capabilities within our corporate organization. We value them as an ecosystem partner and as a true extension of our operating team.”
“RNA knows the diagnostics space. From Nanosphere to Biocartis, RNA has been my valuation firm of choice. They are responsive, efficient and I know that they’ll deliver. I’ve been glad to see their success and growth. It’s well deserved.”
Enter your email address below to receive updates from RNA Advisors.
